Compass Therapeutics (CMPX) Earnings Date & Reports

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CMPX is expected to report earnings to rise 8.40% to -10 cents per share on August 05

Compass Therapeutics CMPX Stock Earnings Reports

Q2'26

Est.

$-0.11

Q1'26

Est.

$-0.10

Q4'25

Beat

by $0.01

Q3'25

Beat

by $0.06

Q2'25

Missed

by $0.02

The last earnings report on May 05 showed earnings per share of -10 cents, meeting the estimate of -10 cents. With 826.25K shares outstanding, the current market capitalization sits at 365.58M.

View a ticker or compare two or three

Compare

CMPX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CMPX